Trials / Conditions / 2019 Novel Coronavirus Disease
2019 Novel Coronavirus Disease
5 registered clinical trials studyying 2019 Novel Coronavirus Disease.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendu NCT05085574 | Leidos Life Sciences | Phase 2 |
| Completed | Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Cli NCT05364268 | AudibleHealth AI, Inc. | — |
| Terminated | Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVI NCT05077969 | Leidos Life Sciences | Phase 2 |
| Completed | LEAP-CT for Treatment of COVID-19 Patients (Master Protocol) NCT05077332 | Leidos Life Sciences | Phase 2 |
| Completed | Observational Cohort of COVID-19 Patients in Hubei Province NCT05615792 | Dao Wen Wang | — |